Search results for 'media+pharma'

Top Kannada hero Darshan, actress Pavithra held in murder case

Top Kannada hero Darshan, actress Pavithra held in murder case

Rediff.com11 Jun 2024

Leading Kannada film actor Darshan Thoogudeepa was arrested on Tuesday in connection with the murder of a man who allegedly made "derogatory" comments against his close friend, police sources said.

Consumer goods firms likely to see an upswing after year of lull

Consumer goods firms likely to see an upswing after year of lull

Rediff.com24 Jul 2024

The Budget proposals are expected to boost the fortunes of consumer goods and fast-moving consumer goods companies, which have been struggling with poor consumer demand for more than a year. The Budget announcements, such as the increase in standard deduction by Rs 25,000 for income-tax payers and slab revisions, will put more money in their hands, boosting consumer demand. Private consumption is also likely to benefit from a new scheme to offer internships to 10 million youths in the country's top 500 companies.

Sun Pharma's m-cap sinks by Rs 8,736 crore in just one day

Sun Pharma's m-cap sinks by Rs 8,736 crore in just one day

Rediff.com18 Jan 2019

The stock was the worst hit among the blue-chips on both BSE and NSE.

Healthcare sector most violative of advertisement rules, says Asci report

Healthcare sector most violative of advertisement rules, says Asci report

Rediff.com23 May 2024

Maximum cases of advertisement norms violations were reported from the healthcare sector during 2023-24, followed by illegal offshore betting and personal care categories, according to the Advertising Standards Council of India's (Asci's) Annual Complaints Report released on Wednesday. The healthcare sector accounted for a maximum 19 per cent or 1,569 of 8,229 advertisements scrutinised by Asci during the year. Illegal offshore betting accounted for 17 per cent, while the share of personal care advertisements was 13 per cent.

'Shah Rukh's Words Found Me When I Needed Them Most'

'Shah Rukh's Words Found Me When I Needed Them Most'

Rediff.com6 Aug 2024

'SRK couldn't have been nicer, empathetic, more sharing and interactive. It really was a wonderful moment.'

Union Budget 2024 remains largely neutral for stock markets in India

Union Budget 2024 remains largely neutral for stock markets in India

Rediff.com25 Jul 2024

Overall market reaction to the Budget was neutral. Investors absorbed the changes to the tax rates (positive for salaried class) and capital gains taxes (CGTs, negative due to the removal of indexation and increases. Other proposals largely pertain to supporting rural development, buybacks taxed as dividends, Custom duty changes that impact multiple sectors, higher outlays for clean energy, etc. There's some moderation in the growth of capex outlay across defence, fer

Indian Biz Sees Hope After Bangladesh SC Order

Indian Biz Sees Hope After Bangladesh SC Order

Rediff.com22 Jul 2024

'Bilateral trade has suffered seriously because of the growing unrest.' 'There is a standstill on both sides amid the curfew.'

'Power shifts to chemists instead of doctors'

'Power shifts to chemists instead of doctors'

Rediff.com22 Aug 2023

'Whichever company offers better incentives, the chemist would prefer it.'

Sun Pharma sues Novartis in US court

Sun Pharma sues Novartis in US court

Rediff.com13 Jun 2013

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.

Five Indians among 40 influential pharma faces

Five Indians among 40 influential pharma faces

Rediff.com19 May 2008

These include former drugs controller M Venkateshwarlu, Ranbaxy CMD Malvinder Mohan Singh, Ranjit Shahani, India chief of Swiss pharma major Novartis AG, Ramaprasad Reddy, chairman Aurobindo Pharma and Rajesh Jain, joint managing director, Panacea Biotec.

Karnataka rolls back quota bill for Kannadigas in jobs

Karnataka rolls back quota bill for Kannadigas in jobs

Rediff.com17 Jul 2024

The Karnataka government on Wednesday put the reservation bill for Kannadigas in private firms on hold amid fierce criticism from business leaders and tech tycoons.

41 firms facing probe donated Rs 2,471 cr to BJP: Petitioners

41 firms facing probe donated Rs 2,471 cr to BJP: Petitioners

Rediff.com23 Mar 2024

Senior advocate Prashant Bhushan, who appeared for the petitioners in the court, said at least 30 shell companies purchased electoral bonds worth over Rs 143 crore.

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Rediff.com9 Apr 2014

Ranbaxy drugs sold in the United States will be gradually rebranded as Sun Pharma treatments

US drug shortage a shot in the arm for Indian pharmaceutical companies

US drug shortage a shot in the arm for Indian pharmaceutical companies

Rediff.com26 Jun 2023

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Nuvama Research analysts said that US price erosion seems to have normalised to its old levels of 6-8 per cent and volumes are picking up with easing of inventory. Similarly, an ICICIdirect analyst noted: "Price erosion intensity has now moderated to a single digit and is expected to tone down a

China moved military forces in disregard of agreements: Jaishankar

China moved military forces in disregard of agreements: Jaishankar

Rediff.com27 Feb 2024

The external affairs minister, speaking at a media summit organised by the TV9 Network, described the rise of India and China as "significant" in the global geopolitical scenario.

'I failed 2 start-ups and lost Rs 2 crores. Pls help'

'I failed 2 start-ups and lost Rs 2 crores. Pls help'

Rediff.com22 Nov 2023

rediffGURU Chandu Nair advises entrepreneurs and enterprises about how to create and build their business.

What lies ahead for Sun Pharma post Ranbaxy merger approval

What lies ahead for Sun Pharma post Ranbaxy merger approval

Rediff.com31 Mar 2015

Sun Pharmaceutical's acquisition of Ranbaxy has received final approvals.

India probes eye drop linked to vision loss in US

India probes eye drop linked to vision loss in US

Rediff.com4 Feb 2023

A three-member team each from the Central Drugs Standard Control Organisation (CDSCO) and the State Drug Controller visited the plant in Tamil Nadu's Kancheepuram, 40 km from Chennai, on Friday after the company recalled the eye drop.

Draft rules propose doctors disclose income from pharma companies

Draft rules propose doctors disclose income from pharma companies

Rediff.com8 Jun 2022

Defining "modern medicine" for the first time, the National Medical Commission (NMC), in its code of conduct, has introduced a major change, proposing the use of "Med Dr" as a prefix for those registered under the NMC Act, 2019, as practitioners of modern medicine.

Merck eyeing lab media company

Merck eyeing lab media company

Rediff.com5 Oct 2006

The sources said HiMedia Lab had been valued at a much higher enterprise value, equivalent to more than three-four times of its current revenue of Rs150 crore by Merck.

Sensex falls to four-week closing low; Sun Pharma plunges

Sensex falls to four-week closing low; Sun Pharma plunges

Rediff.com21 Apr 2015

The Sensex ended at at 27,676, lower by 210 points and the Nifty broke the psychological level of 8,400 to end at 83877 down 70 points.

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

Excise policy: AAP's Goa poll kickbacks detected in I-T, CBI probes, says ED

Excise policy: AAP's Goa poll kickbacks detected in I-T, CBI probes, says ED

Rediff.com31 Mar 2024

Statements of five 'Angadiya' firm operators have also been recorded by the ED to establish the "money trail" of this alleged Rs 45 crore bribe amount.

Investors bet big on cyclicals as economic recovery gathers pace

Investors bet big on cyclicals as economic recovery gathers pace

Rediff.com18 Feb 2021

sharper-than-expected economic recovery back home, analysts say, can fuel a further rally in domestic cyclicals, industrials, and financials as global central banks continue with their easy money policy.

Electoral bonds: Cong says firms donating to BJP got big projects

Electoral bonds: Cong says firms donating to BJP got big projects

Rediff.com15 Mar 2024

The Congress on Friday alleged that the electoral bonds data has exposed 'corrupt tactics' of the Bharatiya Janata Party such as quid pro quo, seeking donations for the company's protection, kickbacks and money laundering through shell companies.

HC grants bail to pharma student held for tweet against Sharad Pawar

HC grants bail to pharma student held for tweet against Sharad Pawar

Rediff.com21 Jun 2022

Justice Jamdar then said that the bench will grant relief to Bhamare in the two cases where his bail pleas had been rejected, while the police are restrained from arresting him in the fourth and the fifth cases.

Market valuations attractive; buy selectively for long term

Market valuations attractive; buy selectively for long term

Rediff.com6 Apr 2023

The sharp correction in the Indian markets from their peak levels has made valuations attractive, say analysts, who advise buying selectively, but only from a long-term perspective. Fifty-six of the Nifty 100 stocks, according to Mahesh Nandurkar, managing director at Jefferies, now trade below the 10-year historical averages, including stocks in financial, select auto, and pharma sectors. "Valuation (one-year forward consensus price-to-earnings, PE) has declined 25 per cent from October 2021 peak, almost matching the 33 per cent price-earnings contraction during the 2011 tightening cycle when repo rates went up by 375 basis points (bps) versus 250 bps this cycle.

Excise policy: ED arrests BRS leader Kavitha after raid; taken to Delhi

Excise policy: ED arrests BRS leader Kavitha after raid; taken to Delhi

Rediff.com15 Mar 2024

BRS leader and former Telangana minister Vemula Prashanth Reddy claimed that Kavitha was taken to Delhi on a flight at 8.45 pm.

Kavitha brought to Delhi after dramatic arrest in excise policy case

Kavitha brought to Delhi after dramatic arrest in excise policy case

Rediff.com16 Mar 2024

The Enforcement Directorate on Friday arrested Bharat Rashtra Samiti leader K Kavitha after an hours-long raid at her premises in Hyderabad and brought her to Delhi for questioning in a money laundering case linked to the now-scrapped Delhi excise policy, agency sources said.

Check out the hottest mutual funds

Check out the hottest mutual funds

Rediff.com19 Aug 2006

Mutual funds predominantly bought engineering, media, pharma, and oil and gas stocks in July

Dr Reddy's sued in US court by S Korean pharma co

Dr Reddy's sued in US court by S Korean pharma co

Rediff.com27 Jan 2017

Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator.

Sensex rises, Nifty holds 8,900; FMCG, Pharma shares lead

Sensex rises, Nifty holds 8,900; FMCG, Pharma shares lead

Rediff.com5 Mar 2015

Sensex rises, Nifty holds 8,900; FMCG, Pharma shares lead.

India's exports decline 7% to $34.48 billion in August

India's exports decline 7% to $34.48 billion in August

Rediff.com15 Sep 2023

India's exports declined by 6.86 per cent to $34.48 billion in August this year as against $37.02 billion in the same month last year, government data showed on Friday. Imports too declined by 5.23 per cent to $58.64 billion as against $61.88 billion recorded in August 2022.

Last hour slide drags markets; IT, pharma shares wilt

Last hour slide drags markets; IT, pharma shares wilt

Rediff.com5 Dec 2014

Infosys, TCS, ICICI Bank and Sun Pharma among the top losers of the hour.

Markets ended lower amid global worry; aviation, pharma gain

Markets ended lower amid global worry; aviation, pharma gain

Rediff.com15 Sep 2015

BSE Metal and Capital Goods indices plunged over 2% followed by counters like Consumer Durables, Auto, Banks and Realty, all falling down between 1-2%.

Exports dip 2.6% in Sep; trade deficit narrows to $19.37 bn

Exports dip 2.6% in Sep; trade deficit narrows to $19.37 bn

Rediff.com13 Oct 2023

Exports contracted by 2.6 per cent to $34.47 billion in September even as the country's merchandise trade deficit narrows to $19.37 billion during the month under review, according to the government data released on Friday. Easing commodity prices helped in cutting down the country's import bill by 15 per cent to $53.84 billion in September, the 10th consecutive month of decline. During April-September this fiscal, exports contracted by 8.77 per cent to $211.4 billion.

ED summons KCR's daughter Kavitha in excise case

ED summons KCR's daughter Kavitha in excise case

Rediff.com8 Mar 2023

The Enforcement Directorate has summoned Telangana Chief Minister K Chandrashekar Rao's daughter K Kavitha in connection with a money laundering case linked to alleged irregularities in the Delhi excise policy, officials said on Wednesday.

Markets fall for 6th straight session; Sun Pharma dips 2%

Markets fall for 6th straight session; Sun Pharma dips 2%

Rediff.com21 Dec 2016

Sun Pharma dipped 2% to Rs 615 on the BSE, its lowest level since November 9, 2016

M&A deals jump 40% to $163 billion in 2022

M&A deals jump 40% to $163 billion in 2022

Rediff.com13 Feb 2023

Strategic deals like the one involving the HDFC twins accounted for a bulk $126 billion of the overall quantum, while transactions involving private equity funds stood at $37 billion, the report by Deloitte, a consultancy firm, said. Despite global headwinds like rising interest rates and elevated inflation levels leading to increased margin pressures for companies, the firm expects the overall activity to remain "strong" in the ongoing 2023.

Demand for Indian generic drugs shot up in China amid Covid surge

Demand for Indian generic drugs shot up in China amid Covid surge

Rediff.com9 Jan 2023

Due to the massive short supply of Paxlovid, demand for Indian generic versions has gone up through Chinese e-commerce platforms.